PlainRecalls
FDA Drug Moderate Class II Terminated

Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02

Reported: March 1, 2017 Initiated: February 7, 2017 #D-0482-2017

Product Description

Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
630 pills (21 bottles x 30 pills per HDPE bottle)
Distribution
Product was distributed to a sold customer in FL.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02. Recalled by RemedyRepack Inc.. Units affected: 630 pills (21 bottles x 30 pills per HDPE bottle).
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 1, 2017. Severity: Moderate. Recall number: D-0482-2017.